Case number 1:22-cv-00032
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 7, 2023 | 61 | REPORT to USPTO on the filing or determination of an action regarding re 1 Complaint (Part 2). (dk) (Entered: 03/07/2023) (1) |
| Mar 7, 2023 | 60 | REPORT to USPTO on the filing or determination of an action regarding re 1 Complaint (Part 1). (dk) (Entered: 03/07/2023) (1) |
| Mar 7, 2023 | 59 | ORDER OF DISMISSAL. This action is DISMISSED WITHOUT PREJUDICE and STRICKEN from the Court's active docket. Signed by Chief District Judge Thomas S Kleeh on 3/7/2023. (dk) (Entered: 03/07/2023) (1) |
| Mar 6, 2023 | 58 | STIPULATION of Dismissal by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Higginbotham, Daniel) (Entered: 03/06/2023) (2) |
| Jan 17, 2023 | 57 | REPLY to Response to Motion re 9 MOTION to Stay This Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action, 12 MOTION to Stay re 8 FirstOrder,, Plaintiffs' Motion to Stay Deadlines Pending Resolution of Plaintiffs' Motion to Stay this Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Higginbotham, Daniel) (Entered: 01/17/2023) (3) |
| Jan 12, 2023 | 56 | Opposition to Plaintiffs' Supplemental Brief in Support of Their Motions to Stay This Case Pending Resolution of Venue Challenge in Delaware ( Other Document ) filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Attachment Declaration of Maria A. Stubbings, # 2 Exhibit 1, # 3 Exhibit 2)(O'Brien, William) (Entered: 01/12/2023) (Exhibit 2) (5) |
| Jan 12, 2023 | 56 | Opposition to Plaintiffs' Supplemental Brief in Support of Their Motions to Stay This Case Pending Resolution of Venue Challenge in Delaware ( Other Document ) filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Attachment Declaration of Maria A. Stubbings, # 2 Exhibit 1, # 3 Exhibit 2)(O'Brien, William) (Entered: 01/12/2023) (Exhibit 1) (5) |
| Jan 12, 2023 | 56 | Opposition to Plaintiffs' Supplemental Brief in Support of Their Motions to Stay This Case Pending Resolution of Venue Challenge in Delaware ( Other Document ) filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Attachment Declaration of Maria A. Stubbings, # 2 Exhibit 1, # 3 Exhibit 2)(O'Brien, William) (Entered: 01/12/2023) (Attachment Declaration of Maria A. Stubbings) (2) |
| Jan 12, 2023 | 56 | Opposition to Plaintiffs' Supplemental Brief in Support of Their Motions to Stay This Case Pending Resolution of Venue Challenge in Delaware ( Other Document ) filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Attachment Declaration of Maria A. Stubbings, # 2 Exhibit 1, # 3 Exhibit 2)(O'Brien, William) (Entered: 01/12/2023) (Main Document) (6) |
| Jan 3, 2023 | 55 | Memorandum in Support re 9 MOTION to Stay This Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action, 12 MOTION to Stay re 8 FirstOrder,, Plaintiffs' Motion to Stay Deadlines Pending Resolution of Plaintiffs' Motion to Stay this Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit A)(Higginbotham, Daniel) (Entered: 01/03/2023) (Exhibit A) (5) |
| Jan 3, 2023 | 55 | Memorandum in Support re 9 MOTION to Stay This Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action, 12 MOTION to Stay re 8 FirstOrder,, Plaintiffs' Motion to Stay Deadlines Pending Resolution of Plaintiffs' Motion to Stay this Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit A)(Higginbotham, Daniel) (Entered: 01/03/2023) (Main Document) (4) |
| Dec 29, 2022 | 54 | CERTIFICATE OF SERVICE by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. Plaintiffs' Responses to Defendant's First Set of Common Requests for Production of Documents and Things (Nos. 1-84). (Higginbotham, Daniel) (Entered: 12/29/2022) (2) |
| Dec 23, 2022 | 53 | RESPONSE by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. to 52 Notice (Other). (O'Brien, William) (Entered: 12/23/2022) (4) |
| Dec 22, 2022 | 52 | NOTICE by Otsuka Pharmaceutical Co., Ltd. Regarding First-Filed Delaware Action (Attachments: # 1 Exhibit A - Stipulated Order)(Higginbotham, Daniel) (Entered: 12/22/2022) (Exhibit A - Stipulated Order) (5) |
| Dec 22, 2022 | 52 | NOTICE by Otsuka Pharmaceutical Co., Ltd. Regarding First-Filed Delaware Action (Attachments: # 1 Exhibit A - Stipulated Order)(Higginbotham, Daniel) (Entered: 12/22/2022) (Main Document) (3) |
| Dec 5, 2022 | 51 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Requests for Production of Documents dated 11.28.22). (O'Brien, William) (Entered: 12/05/2022) (2) |
| Aug 5, 2022 | 50 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. (Defendants' Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1)). (O'Brien, William) |
| Jun 24, 2022 | 48 | Order (2) Docket Text:ORDER GRANTING DEFENDANTS' MOTION TO FILE BRIEF UNDER SEAL. The Court GRANTS the motion [ECF No. [47]] and DIRECTS the Clerk of Court to file Reply in Support of Mylan Laboratories Limited's and Viatris Inc.'s Motion to Dismiss [ECF No. 47-1] and all attachments thereto, UNDER SEAL. Signed by Chief District Judge Thomas S Kleeh on 6/24/2022. (wrr) |
| Jun 21, 2022 | 46 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. (Defendants' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1)). (O'Brien, William) |
| Jun 21, 2022 | 45 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. certifying service of Plaintiffs' Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1). (Higginbotham, Daniel) |
| Jun 17, 2022 | 44 | Other Document (20) Docket Text:Plaintiffs' Answer and Defenses to Defendant Mylan Pharmaceuticals Inc.'s Counterclaims Other Document re [18] Answer to Complaint, Counterclaim filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Higginbotham, Daniel) |
| Jun 17, 2022 | 42 | Order (2) Docket Text:ORDER GRANTING PLAINTIFFS' [41] MOTION TO FILE BRIEF UNDER SEAL. Signed by Chief District Judge Thomas S Kleeh on 6/17/2022. (dk) |
| Jun 15, 2022 | 40 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [28] Motion of Emily J. Greb for Leave to Appear Pro Hac Vice on behalf of Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 6/15/2022. (dk) |
| Jun 15, 2022 | 39 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [31] Motion of Shannon M. Bloodworth for Leave to Appear Pro Hac Vice on behalf of Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 6/15/2022. (dk) |
| Jun 15, 2022 | 38 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [30] Motion of Maria A. Stubbings for Leave to Appear Pro Hac Vice on behalf of Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 6/15/2022. (dk) |
| Jun 15, 2022 | 37 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [29] Motion of Jonathan Tietz for Leave to Appear Pro Hac Vice on behalf of Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 6/15/2022. (dk) |
| Jun 14, 2022 | 34 | Order (1) Docket Text:ORDER ADOPTING STIPULATION. The Court ADOPTS the stipulation and EXTENDS Plaintiffs' time to respond to Defendants' Motion to Dismiss (ECF No. [15]) to June 16, 2022. Signed by Chief District Judge Thomas S Kleeh on 6/14/2022. (dk) |
| Jun 13, 2022 | 32 | Report of Rule 26(f) Planning Meeting (18) Docket Text: REPORT of Rule 26(f) Planning Meeting. (Higginbotham, Daniel) |
| Jun 13, 2022 | 31 | Supplement (1) |
| Jun 13, 2022 | 31 | Main Document (4) Docket Text: MOTION for Leave to Appear pro hac vice of Shannon Bloodworth by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # (1) Supplement)(Copland, Gordon) |
| Jun 13, 2022 | 30 | Proposed Order (1) |
| Jun 13, 2022 | 30 | Main Document (4) Docket Text: MOTION for Leave to Appear pro hac vice of Maria Stubbings by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # (1) Proposed Order)(Copland, Gordon) |
| Jun 13, 2022 | 29 | Proposed Order (1) |
| Jun 13, 2022 | 29 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jonathan Tietz by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # (1) Proposed Order)(Copland, Gordon) |
| Jun 13, 2022 | 28 | Proposed Order (1) |
| Jun 13, 2022 | 28 | Main Document (4) Docket Text: MOTION for Leave to Appear pro hac vice of Emily Greb by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # (1) Proposed Order)(Copland, Gordon) |
| Jun 10, 2022 | 27 | Proposed Order Proposed Order Granting Joint Motion for Extension of Time (1) |
| Jun 10, 2022 | 27 | Main Document (3) Docket Text: Joint MOTION for Extension of Time to File Parties' Planning Report by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Proposed Order Proposed Order Granting Joint Motion for Extension of Time)(Higginbotham, Daniel) |
| Jun 10, 2022 | 26 | Stipulation (3) Docket Text: STIPULATION re [15] MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM Stipulation Extending Plaintiffs' Time to Respond to Motion to Dismiss by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Higginbotham, Daniel) |
| Jun 9, 2022 | 25 | Order on Motion for Extension of Time to File (3) Docket Text:ORDER GRANTING [24] JOINT MOTION FOR EXTENSION OF TIME. Rule 26 Meeting Report due by 6/10/2022. Signed by Chief District Judge Thomas S Kleeh on 6/9/2022. (dk) |
| Jun 8, 2022 | 24 | Motion for Extension of Time to File (3) Docket Text: Joint MOTION for Extension of Time to File Parties' Planning Report by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Higginbotham, Daniel) |
| Jun 3, 2022 | 23 | Main Document (20) Docket Text: REPLY to Response to Motion re [9] MOTION to Stay This Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit A - NEF Delaware, # (2) Exhibit B - NEF NDWV)(Higginbotham, Daniel) |
| Jun 3, 2022 | 22 | Reply to Response to Motion (8) Docket Text: REPLY to Response to Motion re [9] MOTION to Stay This Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action, [12] MOTION to Stay re [8] FirstOrder,, Plaintiffs' Motion to Stay Deadlines Pending Resolution of Plaintiffs' Motion to Stay this Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Higginbotham, Daniel) |
| Jun 3, 2022 | 23 | Exhibit A - NEF Delaware (3) |
| Jun 3, 2022 | 23 | Exhibit B - NEF NDWV (5) |
| Jun 1, 2022 | 21 | Order on Motion for Extension of Time to File (1) Docket Text:ORDER GRANTING EXTENSION OF TIME TO FILE PARTIES' PLANNING REPORT (ECF. NO. [20]). Rule 26 Meeting Report due by 6/8/2022. Signed by Chief District Judge Thomas S Kleeh on 6/1/2022. (dk) |
| Jun 1, 2022 | 20 | Proposed Order (1) |
| Jun 1, 2022 | 20 | Main Document (3) Docket Text: Joint MOTION for Extension of Time to File Parties' Planning Report by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
| May 31, 2022 | 19 | Corporate Disclosure Statement (3) Docket Text: Corporate Disclosure Statement by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. identifying Corporate Parent Viatris Inc. for Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc... (Copland, Gordon) |
| May 27, 2022 | 18 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint,, Mylan Pharm. Answers defenses and, COUNTERCLAIM against H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. by Mylan Pharmaceuticals Inc..(Copland, Gordon) |
| May 27, 2022 | 17 | Exhibit Ex E - Celgene II (43) |
| May 27, 2022 | 17 | Exhibit Ex D - Boehringer (9) |
| May 27, 2022 | 17 | Exhibit Ex C - Takeda (31) |
| May 27, 2022 | 17 | Exhibit Ex B - Novartis II (16) |
| May 27, 2022 | 17 | Exhibit Ex A - Novartis (15) |
| May 27, 2022 | 17 | Main Document (23) Docket Text: Memorandum in Opposition re [9] MOTION to Stay This Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action, [12] MOTION to Stay re [8] FirstOrder,, Plaintiffs' Motion to Stay Deadlines Pending Resolution of Plaintiffs' Motion to Stay this Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # (1) Exhibit Ex A - Novartis, # (2) Exhibit Ex B - Novartis II, # (3) Exhibit Ex C - Takeda, # (4) Exhibit Ex D - Boehringer, # (5) Exhibit Ex E - Celgene II)(Copland, Gordon) |
| May 27, 2022 | 15 | Motion to Dismiss for Failure to State a Claim (3) Docket Text: MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Mylan Laboratories Limited, Viatris Inc.. (Copland, Gordon) |
| May 18, 2022 | 14 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [10] Motion for Leave to Appear Pro Hac Vice of Jeanette M. Roorda. Signed by Chief District Judge Thomas S Kleeh on 05/18/2022. (kam) |
| May 17, 2022 | 13 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Brandon M. White on behalf of All Defendants (White, Brandon) |
| May 17, 2022 | 12 | Motion to Stay (3) Docket Text: MOTION to Stay re [8] FirstOrder,, Plaintiffs' Motion to Stay Deadlines Pending Resolution of Plaintiffs' Motion to Stay this Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Higginbotham, Daniel) |
| May 16, 2022 | 10 | Proposed Order (1) |
| May 16, 2022 | 10 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jeanette M. Roorda by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
| May 13, 2022 | 9 | Exhibit B (2) |
| May 13, 2022 | 9 | Exhibit A (6) |
| May 13, 2022 | 9 | Attachment Plaintiffs' Brief in Support of Their Motion to Stay (20) |
| May 13, 2022 | 9 | Main Document (3) Docket Text: MOTION to Stay This Second-Filed Case Pending Resolution of Venue Challenge in First-Filed Delaware Action by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Attachment Plaintiffs' Brief in Support of Their Motion to Stay, # (2) Exhibit A, # (3) Exhibit B)(Higginbotham, Daniel) |
| Apr 18, 2022 | 8 | FirstOrder (6) Docket Text:FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 5/18/2022. Rule 26 Meeting Report due by 6/1/2022. Discovery due by 6/20/2022. Signed by Chief District Judge Thomas S Kleeh on 4/18/2022. (dk) |
| Apr 14, 2022 | 7 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. (Copland, Gordon) |
| Apr 11, 2022 | 6 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [1] Complaint (Part 2). (dk) |
| Apr 11, 2022 | 5 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [1] Complaint (Part 1). (dk) |
| Apr 8, 2022 | 4 | Corporate Disclosure Statement (1) Docket Text: Corporate Disclosure Statement by H. Lundbeck A/S. (dk) |
| Apr 8, 2022 | 3 | Corporate Disclosure Statement (1) Docket Text: Corporate Disclosure Statement by Otsuka Pharmaceutical Co., Ltd. identifying Corporate Parent Otsuka Holdings Co., Ltd. (dk) |
| Apr 8, 2022 | 1 | Complaint* (1) |
| Apr 8, 2022 | 2 | Other Document (2) Docket Text: SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. (dk) |
| Apr 8, 2022 | 1 | Civil Cover Sheet (2) |
| Apr 8, 2022 | 1 | Exhibit M - 553 Patent (13) |
| Apr 8, 2022 | 1 | Exhibit L - 803 Patent (13) |
| Apr 8, 2022 | 1 | Exhibit K - Issue Notification (2) |
| Apr 8, 2022 | 1 | Exhibit J - 057 Patent (12) |
| Apr 8, 2022 | 1 | Exhibit I - Issue Notification (2) |
| Apr 8, 2022 | 1 | Exhibit H - 427 Patent (9) |
| Apr 8, 2022 | 1 | Exhibit G - Redetermination of Patent Term Adjustment (17) |
| Apr 8, 2022 | 1 | Exhibit F - 469 Patent (67) |
| Apr 8, 2022 | 1 | Exhibit E - Application (7) |
| Apr 8, 2022 | 1 | Exhibit D - Patent 679 (19) |
| Apr 8, 2022 | 1 | Exhibit C - Application (8) |
| Apr 8, 2022 | 1 | Exhibit B - 313 Patent (21) |
| Apr 8, 2022 | 1 | Exhibit A - 680 Patent (20) |
| Apr 8, 2022 | 1 | Main Document (37) Docket Text: COMPLAINT against Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc., filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Filing Fee PAID: $402. Receipt #AWVNDC-3460206. (Attachments: # (1) Exhibit A - 680 Patent, # (2) Exhibit B - 313 Patent, # (3) Exhibit C - Application, # (4) Exhibit D - Patent 679, # (5) Exhibit E - Application, # (6) Exhibit F - 469 Patent, # (7) Exhibit G - Redetermination of Patent Term Adjustment, # (8) Exhibit H - 427 Patent, # (9) Exhibit I - Issue Notification, # (10) Exhibit J - 057 Patent, # (11) Exhibit K - Issue Notification, # (12) Exhibit L - 803 Patent, # (13) Exhibit M - 553 Patent, # (14) Civil Cover Sheet) (dk) |
